Sensitization vaccines / reinforcement of malaria.

A kit of parts comprising: - a recombinant adenovirus without replication capacity in a pharmaceutically acceptable excipient, said adenovirus comprising a heterologous nucleic acid encoding a circumsporozoite (CS) antigen that comes from a parasite that causes malaria; and - an adjuvant enhanced proteinaceous antigen; wherein said recombinant adenovirus is selected from the group consisting of human adenovirus serotype 11, 24, 26, 34, 35, 48, 49 and 50 and wherein said recombinant adenovirus without replication capability is a sensitization composition and said adjuvant enhanced proteinaceous antigen is a reinforcing composition.